Lynn Resnick

738 total citations
16 papers, 476 citations indexed

About

Lynn Resnick is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Lynn Resnick has authored 16 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 6 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Lynn Resnick's work include Chemical Synthesis and Analysis (2 papers), Neuroscience and Neuropharmacology Research (2 papers) and Alzheimer's disease research and treatments (2 papers). Lynn Resnick is often cited by papers focused on Chemical Synthesis and Analysis (2 papers), Neuroscience and Neuropharmacology Research (2 papers) and Alzheimer's disease research and treatments (2 papers). Lynn Resnick collaborates with scholars based in United States and Canada. Lynn Resnick's co-authors include Myles Fennell, Kathlyn A. Parker, Peter Wipf, Donna M. Huryn, Spencer Knapp, Santosh Nandan, Radka Graf, Bin Luo, Zoë A. Hughes and Brian J. Platt and has published in prestigious journals such as Neurology, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Lynn Resnick

16 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lynn Resnick United States 10 204 136 111 61 60 16 476
Joseph W. Gunnet United States 19 277 1.4× 211 1.6× 240 2.2× 55 0.9× 173 2.9× 43 974
Lesley A. Howell United Kingdom 15 347 1.7× 82 0.6× 38 0.3× 19 0.3× 165 2.8× 27 566
Thomas Troxler Switzerland 10 262 1.3× 58 0.4× 38 0.3× 44 0.7× 180 3.0× 17 556
Jason C. Rech United States 17 239 1.2× 338 2.5× 36 0.3× 40 0.7× 107 1.8× 27 847
Anne Bonnaud France 9 319 1.6× 92 0.7× 58 0.5× 31 0.5× 140 2.3× 13 598
Kohfuku Kohda Japan 13 305 1.5× 101 0.7× 79 0.7× 34 0.6× 170 2.8× 33 682
Ji-Young Mun South Korea 14 272 1.3× 75 0.6× 42 0.4× 37 0.6× 81 1.4× 52 677
Miguel Guerrero United States 18 694 3.4× 79 0.6× 43 0.4× 102 1.7× 202 3.4× 29 909
Camilla Göktürk Sweden 12 423 2.1× 33 0.2× 23 0.2× 58 1.0× 48 0.8× 17 648
Luigi Stasi Italy 11 118 0.6× 128 0.9× 25 0.2× 12 0.2× 71 1.2× 20 325

Countries citing papers authored by Lynn Resnick

Since Specialization
Citations

This map shows the geographic impact of Lynn Resnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn Resnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn Resnick more than expected).

Fields of papers citing papers by Lynn Resnick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn Resnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn Resnick. The network helps show where Lynn Resnick may publish in the future.

Co-authorship network of co-authors of Lynn Resnick

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn Resnick. A scholar is included among the top collaborators of Lynn Resnick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn Resnick. Lynn Resnick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Resnick, Lynn, et al.. (2024). Characterization of BHV-7000: A Novel Kv7.2/7.3 Activator for the Treatment of Seizures (S29.006). Neurology. 102(7_supplement_1). 2 indexed citations
2.
Johnston, Paul A., Malabika Sen, Yun Hua, et al.. (2015). HCS Campaign to Identify Selective Inhibitors of IL-6-Induced STAT3 Pathway Activation in Head and Neck Cancer Cell Lines. Assay and Drug Development Technologies. 13(7). 356–376. 24 indexed citations
3.
LaPorte, Matthew G., Feng Zhang, Malabika Sen, et al.. (2014). 2-Guanidinoquinazolines as new inhibitors of the STAT3 pathway. Bioorganic & Medicinal Chemistry Letters. 24(21). 5081–5085. 16 indexed citations
4.
Gupta, Tushar, Sandlin P. Seguin, Lynn Resnick, et al.. (2014). Synthesis and structure–activity relationships of small molecule inhibitors of the simian virus 40 T antigen oncoprotein, an anti-polyomaviral target. Bioorganic & Medicinal Chemistry. 22(22). 6490–6502. 5 indexed citations
5.
Huryn, Donna M., Lynn Resnick, & Peter Wipf. (2013). Contributions of Academic Laboratories to the Discovery and Development of Chemical Biology Tools. Journal of Medicinal Chemistry. 56(18). 7161–7176. 30 indexed citations
6.
Pu, Jun, Kangwen Deng, John A. Butera, et al.. (2010). De novo synthesis of teleocidin B analogs. Tetrahedron. 66(11). 1963–1972. 5 indexed citations
7.
Braithwaite, Steven P., Ralf S. Schmid, He Dong, et al.. (2010). Inhibition of c-Jun kinase provides neuroprotection in a model of Alzheimer's disease. Neurobiology of Disease. 39(3). 311–317. 70 indexed citations
8.
Ring, Robert H., Lee E. Schechter, Sarah K. Leonard, et al.. (2009). Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist. Neuropharmacology. 58(1). 69–77. 124 indexed citations
9.
Lovering, Frank, Weiheng Wang, Lynn Resnick, et al.. (2009). Identification and SAR of squarate inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2). Bioorganic & Medicinal Chemistry. 17(9). 3342–3351. 19 indexed citations
10.
Wang, Zheng & Lynn Resnick. (2008). Practical asymmetric synthesis of a novel γ-secretase inhibitor. Tetrahedron. 64(27). 6440–6443. 12 indexed citations
11.
Kreft, Anthony F., Magid Abou‐Gharbia, Ann Aulabaugh, et al.. (2008). P2‐337: Characterization of the affinity of GSI‐953 for binding to gamma‐secretase and comparison to benchmark gamma‐secretase inhibitors. Alzheimer s & Dementia. 4(4S_Part_14). 2 indexed citations
12.
Zhang, Minsheng, George Diamantidis, Dennis Kubrak, et al.. (2007). Asymmetric synthesis of novel α-amino acids with β-branched side chains. Bioorganic & Medicinal Chemistry Letters. 17(9). 2401–2403. 7 indexed citations
13.
Resnick, Lynn, et al.. (2006). A practical synthesis of 3-ethyl-l-norvaline. Tetrahedron Asymmetry. 17(5). 846–849. 5 indexed citations
14.
Resnick, Lynn & Myles Fennell. (2004). Targeting JNK3 for the treatment of neurodegenerative disorders. Drug Discovery Today. 9(21). 932–939. 99 indexed citations
15.
Parker, Kathlyn A. & Lynn Resnick. (1995). The First Total Synthesis of a Pyripyropene-type ACAT Inhibitor, (.+-.)-GERI-BP001. The Journal of Organic Chemistry. 60(17). 5726–5728. 29 indexed citations
16.
Knapp, Spencer, Santosh Nandan, & Lynn Resnick. (1992). Synthesis of the liposidomycin diazepanone. Tetrahedron Letters. 33(38). 5485–5486. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026